Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 1,133 | 1,863 | 1,139 | 4,653 | 1,780 |
| Cost of Goods | 253 | 22 | 353 | 298 | 44 |
| Gross Profit | 880 | 1,841 | 786 | 4,355 | 1,736 |
| Operating Expenses | 15,587 | 14,506 | 13,279 | 12,067 | 12,305 |
| Operating Income | -14,454 | -12,643 | -12,140 | -7,414 | -10,525 |
| Other Income | 107 | 349 | 25 | 7 | 8 |
| Pre-tax Income | -14,347 | -12,294 | -12,115 | -7,407 | -10,517 |
| Net Income Continuous | -14,347 | -12,294 | -12,115 | -7,407 | -10,517 |
| Net Income | $-14,347 | $-12,294 | $-12,115 | $-7,407 | $-10,517 |
| EPS Basic Total Ops | -0.71 | -0.61 | -0.59 | -0.37 | -0.54 |
| EPS Basic Continuous Ops | -0.71 | -0.61 | -0.59 | -0.37 | -0.54 |
| EPS Diluted Total Ops | -0.71 | -0.61 | -0.59 | -0.37 | -0.54 |
| EPS Diluted Continuous Ops | -0.71 | -0.61 | -0.59 | -0.37 | -0.54 |
| EBITDA(a) | $-14,359 | $-12,615 | $-12,074 | $-7,348 | $-10,466 |